Matches in Wikidata for { <http://www.wikidata.org/entity/Q88916574> ?p ?o ?g. }
- Q88916574 description "article scientifique publié en 2018" @default.
- Q88916574 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q88916574 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q88916574 description "scientific article published on 01 August 2018" @default.
- Q88916574 description "wetenschappelijk artikel" @default.
- Q88916574 description "наукова стаття, опублікована в серпні 2018" @default.
- Q88916574 name "A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease" @default.
- Q88916574 name "A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease" @default.
- Q88916574 type Item @default.
- Q88916574 label "A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease" @default.
- Q88916574 label "A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease" @default.
- Q88916574 prefLabel "A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease" @default.
- Q88916574 prefLabel "A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease" @default.
- Q88916574 P1433 Q88916574-16453B2A-6C12-44C8-B546-82BEB9AAA347 @default.
- Q88916574 P1476 Q88916574-46D00C35-7C86-4E64-960D-864AE7917464 @default.
- Q88916574 P2093 Q88916574-083B7D01-FCEA-4B3C-B2EC-523994DD3DA2 @default.
- Q88916574 P2093 Q88916574-23B28CDC-DAE7-4A60-9E46-5EEC9F1555B2 @default.
- Q88916574 P2093 Q88916574-2769D5EF-C043-42C8-82F5-586E5F6927FF @default.
- Q88916574 P2093 Q88916574-2D89EC9A-0D01-4236-9605-04152EBC8F05 @default.
- Q88916574 P2093 Q88916574-2FC53053-6BAC-44F1-A39A-54A6EAFFD5D7 @default.
- Q88916574 P2093 Q88916574-9574B5D1-F4FE-490A-A616-A61E1BA42C1E @default.
- Q88916574 P2093 Q88916574-AC286A6A-D560-41F9-AA7D-76A7E4391DC9 @default.
- Q88916574 P2093 Q88916574-B3135FEE-3D5F-45D2-B698-C8FC95AF5F56 @default.
- Q88916574 P2093 Q88916574-C7A86F6F-FD3E-4E2B-BF92-9B674E378EED @default.
- Q88916574 P2093 Q88916574-C83AB769-3F61-493A-908C-AA9D924CB99A @default.
- Q88916574 P2093 Q88916574-D554A4B1-D059-4B22-86E8-E85DA231E307 @default.
- Q88916574 P2093 Q88916574-D960E585-9C20-4FC1-A01B-B6810D1C7A40 @default.
- Q88916574 P275 Q88916574-beb297d6-8ca4-421f-a7b7-9b2c0a7e124a @default.
- Q88916574 P2860 Q88916574-1447B262-76B8-49EA-80D8-AD5AC2D38091 @default.
- Q88916574 P2860 Q88916574-1945C523-C2FC-48A1-9302-F22FF66ADB0B @default.
- Q88916574 P2860 Q88916574-345A0E79-66C0-4B15-A3AC-2D3ED10F558E @default.
- Q88916574 P2860 Q88916574-42016199-57E9-41CB-AA31-BCD08D1EEEB3 @default.
- Q88916574 P2860 Q88916574-49202FF9-7185-4D1F-80EA-636AAA39E6F7 @default.
- Q88916574 P2860 Q88916574-49C7BD0A-D7CE-4929-A0B9-BB8EC622B919 @default.
- Q88916574 P2860 Q88916574-4FD11E26-7BCE-4ACE-9D4F-7BD9AAC09C81 @default.
- Q88916574 P2860 Q88916574-5D081BAE-9AF6-4862-835C-932CB0AEE9B1 @default.
- Q88916574 P2860 Q88916574-76325F7B-C008-4075-97C1-7FB1E926DDD9 @default.
- Q88916574 P2860 Q88916574-763BB5A7-DDA0-43F3-8ECD-912DE452E4A0 @default.
- Q88916574 P2860 Q88916574-78E5B1C5-3D20-407A-BCA5-0993E8250DEC @default.
- Q88916574 P2860 Q88916574-82833D5E-5CC2-4450-886B-A29EAAF98572 @default.
- Q88916574 P2860 Q88916574-8A68524A-C1C7-4204-BF9D-B4CDDDDE7869 @default.
- Q88916574 P2860 Q88916574-93AA7F10-5F08-49C5-8E03-B5304967CCCE @default.
- Q88916574 P2860 Q88916574-93F682BD-5802-4C5E-9173-1DB24747BC3E @default.
- Q88916574 P2860 Q88916574-991D1FB7-F413-408E-B8F1-3CCF68E2D3F5 @default.
- Q88916574 P2860 Q88916574-AEF808CA-4242-4F96-8305-98DB9EC8E81D @default.
- Q88916574 P2860 Q88916574-CB7EA19C-9E9B-42C3-B338-B55C1A8EACCC @default.
- Q88916574 P2860 Q88916574-CCD132E5-48A8-408C-A6A3-4478CB4EC89A @default.
- Q88916574 P2860 Q88916574-DCA34215-2C7D-4DD7-908A-7B464864186E @default.
- Q88916574 P2860 Q88916574-E03681E5-5C55-498E-98DC-D94BEC4C4ABF @default.
- Q88916574 P2860 Q88916574-E20C9E22-E289-40EE-B863-7653181D6085 @default.
- Q88916574 P304 Q88916574-F17C4197-EA74-4C1D-BC0C-7E3F39B4372B @default.
- Q88916574 P31 Q88916574-3C34525E-1D99-4462-84D9-0BD68E24AF7A @default.
- Q88916574 P356 Q88916574-420C72B2-C0E8-482B-AF3C-3D1F6FA357B9 @default.
- Q88916574 P433 Q88916574-C19C6DA2-9650-4A59-8C40-233ED60F0079 @default.
- Q88916574 P478 Q88916574-748928EA-BA95-4BF3-8701-2F1A20FA8DC5 @default.
- Q88916574 P50 Q88916574-AEF8B2C0-DF7F-4E55-92C9-3A692A9167C1 @default.
- Q88916574 P577 Q88916574-EBFBFA5F-1511-4241-9773-5357441A6AEC @default.
- Q88916574 P6216 Q88916574-cc4c4455-44ea-4d22-a29e-22a050bcbf06 @default.
- Q88916574 P698 Q88916574-88F96E59-840F-4B1D-AAD5-C17CDAFBDC7A @default.
- Q88916574 P921 Q88916574-AA66E81E-976B-4BDB-BEDA-191579564A17 @default.
- Q88916574 P921 Q88916574-C96DAFD6-C81F-403B-9840-E70E1D480875 @default.
- Q88916574 P932 Q88916574-3A4A206D-B142-4CC9-9971-324ECC3C283A @default.
- Q88916574 P356 JJY070 @default.
- Q88916574 P698 29846530 @default.
- Q88916574 P1433 Q15817379 @default.
- Q88916574 P1476 "A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease" @default.
- Q88916574 P2093 "Bal R Bhandari" @default.
- Q88916574 P2093 "Corey A Siegel" @default.
- Q88916574 P2093 "Emily Wendt" @default.
- Q88916574 P2093 "John S Sundy" @default.
- Q88916574 P2093 "Ke Wang" @default.
- Q88916574 P2093 "Keith A Friedenberg" @default.
- Q88916574 P2093 "Matt McKevitt" @default.
- Q88916574 P2093 "Sally Zhao" @default.
- Q88916574 P2093 "Scott D Lee" @default.
- Q88916574 P2093 "Stefan Schreiber" @default.
- Q88916574 P2093 "Ursula Seidler" @default.
- Q88916574 P2093 "Ziad H Younes" @default.
- Q88916574 P275 Q34179348 @default.
- Q88916574 P2860 Q27306938 @default.
- Q88916574 P2860 Q28202504 @default.
- Q88916574 P2860 Q28273481 @default.
- Q88916574 P2860 Q33541428 @default.
- Q88916574 P2860 Q33766675 @default.
- Q88916574 P2860 Q34255362 @default.
- Q88916574 P2860 Q34365574 @default.
- Q88916574 P2860 Q34574245 @default.
- Q88916574 P2860 Q36236021 @default.
- Q88916574 P2860 Q37100247 @default.
- Q88916574 P2860 Q37384864 @default.
- Q88916574 P2860 Q37561775 @default.
- Q88916574 P2860 Q37706103 @default.
- Q88916574 P2860 Q38125012 @default.
- Q88916574 P2860 Q38265674 @default.
- Q88916574 P2860 Q38962353 @default.
- Q88916574 P2860 Q39120032 @default.
- Q88916574 P2860 Q42514321 @default.
- Q88916574 P2860 Q44512440 @default.
- Q88916574 P2860 Q45967926 @default.
- Q88916574 P2860 Q50931443 @default.